期刊簡介 | |||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | Infection and Drug Resistance LetPub Score 6.5
50 ratings
Rate
Reputation 7.2 Influence 5.3 Speed 9.0 | ||||||||||||||||||||||||
期刊簡稱 | INFECT DRUG RESIST | ||||||||||||||||||||||||
ISSN | 1178-6973 | ||||||||||||||||||||||||
h-index | 27 | ||||||||||||||||||||||||
CiteScore |
| ||||||||||||||||||||||||
自引率 (2023-2024) | 6.90%自引率趨勢 | ||||||||||||||||||||||||
掲載範囲 |
| ||||||||||||||||||||||||
官方網站 | https://www.dovepress.com/infection-and-drug-resistance-journal | ||||||||||||||||||||||||
在線稿件提交 | https://www.dovepress.com/submit_step_1.php | ||||||||||||||||||||||||
開放訪問 | Yes | ||||||||||||||||||||||||
出版商 | Dove Medical Press Ltd. | ||||||||||||||||||||||||
主題領域 | Medicine | ||||||||||||||||||||||||
出版國/地區 | UNITED STATES | ||||||||||||||||||||||||
發行頻率 | |||||||||||||||||||||||||
創刊年 | 0 | ||||||||||||||||||||||||
每年文章數 | 682每年文章數趨勢 | ||||||||||||||||||||||||
黃金OA百分比 | 98.64% | ||||||||||||||||||||||||
OA Related Info | APC: Yes( USD3300; ) APC waiver:Check Notes Other charges: No Keywords: bacterial infection、viral infection、fungal infection、antibiotic resistance、anti-infective drugs、infection control Useful LinksAims & ScopeAuthor InstructionsEditorial BoardAnonymous peer review | ||||||||||||||||||||||||
Web of Science 四分位 ( 2023-2024) | WOS Quartile: Q2
| ||||||||||||||||||||||||
索引 (SCI or SCIE) | Science Citation Index Expanded | ||||||||||||||||||||||||
鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1178-6973%5BISSN%5D | ||||||||||||||||||||||||
平均審稿時間 * | 來自出版商的數據: 來自作者的數據: 16 Weeks | ||||||||||||||||||||||||
競爭力 * | 來自作者的數據: | ||||||||||||||||||||||||
參考鏈接 |
| ||||||||||||||||||||||||
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。 |
|
首頁 上一頁 1 2 3 下一頁 末頁 (頁 | |
[Infection and Drug Resistance] 的評論 | 撰寫評論 |
作者: 領域: 審稿時間: 0.0 month(s) 結果: 撰寫評論 |
2024-10-13 10:17:59 評論於 (0) 讚! | |
作者: 太山德本 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-05-13 17:12:49 評論於 Will the revision be reviewed externally?(0) 讚! | 太山德本 |
作者: 太山德本 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-04-27 15:54:29 評論於 Is the revision rejected?(0) 讚! | 太山德本 |
作者: Marsh Blake 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-04-19 09:06:13 評論於 Hello, how is your initial review going? It's been almost a month for me and I'm still in the initial review process(0) 讚! | Marsh Blake |
作者: 太山德本 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-04-08 16:56:37 評論於 Do you have a display for 2GX?(0) 讚! | 太山德本 |
作者: 太山德本 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-04-08 10:05:49 評論於 Review speed: 4.0 | Submission hit rate: 50.0 Emphasized research direction: bioinformatics Sharing experience: Does 2GX represent a rejection?(0) 讚! | 太山德本 |
作者: 江南谷菱 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-04-02 16:03:59 評論於 It has been over a month for me(0) 讚! | 江南谷菱 |
作者: 狒狒1 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-03-21 16:49:00 評論於 Do we need to edit this journal?(0) 讚! | 狒狒1 |
作者: 巴蜀语柔 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-03-04 22:51:58 評論於 What does submission status 1AB mean?(0) 讚! | 巴蜀语柔 |
作者: 犬走鸿轩 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-02-29 22:46:22 評論於 Is it still normal to be in the initial review after two weeks?(0) 讚! | 犬走鸿轩 |
作者: 豆花❀ 領域: 医学 審稿時間: 2.0 month(s) 結果: 拒稿 撰寫評論 |
2024-02-12 14:23:35 評論於 Submitted on November 20, 2023. Notice sent on January 31, 2024 for incomplete reviewers(0) 讚! | 豆花❀ |
作者: 无极志行 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-01-13 12:49:32 評論於 How long does the external audit take?(0) 讚! | 无极志行 |
作者: 东海浩旷 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-01-02 18:40:15 評論於 How long did it take to find the reviewers?(0) 讚! | 东海浩旷 |
作者: 振英mm 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-12-29 21:44:17 評論於 Review speed: 3.0 | Submission hit rate: 50.0 Experience sharing: Acceptance after two rounds of revisions, taking about 3 months from submission(0) 讚! | 振英mm |
作者: 悦人少女 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-12-28 20:36:41 評論於 Review speed: 3.0 | Submission hit rate: 50.0 Emphasis on research direction: bioinformatics sharing experience: Was rejected after 3 months, found two reviewers, one gave good feedback, the other seemed to be a clinician. I used a machine learning model to predict a certain disease, the performance was very good, but he immediately said it was meaningless because clinical diagnosis should be based on imaging results. Without imaging, the selected indicators definitely cannot predict, etc. Really frustrated, if everything is included, doctors will diagnose it, there is significance in me doing this model...... Not understanding and not respecting. It's not an article within their own field, at least hope they can be quiet(0) 讚! | 悦人少女 |
作者: 犬走鸿轩 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-12-19 18:09:42 評論於 Hello, have you won?(0) 讚! | 犬走鸿轩 |
作者: Sherry Louie 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-12-12 19:34:26 評論於 Did you win?(0) 讚! | Sherry Louie |
作者: 犬走鸿轩 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-12-07 11:50:59 評論於 I am so anxious(0) 讚! | 犬走鸿轩 |
作者: 犬走鸿轩 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-12-05 17:37:10 評論於 Hello, may I ask if your current status has changed?(0) 讚! | 犬走鸿轩 |
作者: 璃月雅致 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-12-05 08:37:33 評論於 It has been 20 days and I have turned into 2D(0) 讚! | 璃月雅致 |
作者: 璃月雅致 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-11-14 18:39:02 評論於 Research emphasis: sharing experiences of clinical infections: Is everyone else progressing quickly? Why has my status 2B (reviewer 1 approved the manuscript) been maintained for two weeks, causing me anxiety?(0) 讚! | 璃月雅致 |
作者: 书生松奇 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-09-04 19:23:03 評論於 Review speed: 2.0; Emphasized research field: Pharmaceutics; Experience sharing on drug resistance: Overall speed is fast, editors are nice, and layout fee is slightly high(0) 讚! | 书生松奇 |
作者: 北风子默 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-08-30 09:26:55 評論於 Is ethical approval a requirement for submission? I have not submitted it yet(0) 讚! | 北风子默 |
作者: 慕珊mio 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-08-17 11:30:26 評論於 7.13 submitted, unevaluated new submission after 3 weeks, peer review begins on 8.3, two or more peer reviewers assigned on 8.5, first report returned on 8.9, ethics approval and raw data uploaded on 8.10, then rejected by publisher on 8.11, reason being how informed consent was obtained from one-year-old children in retrospective analysis, total nonsense(0) 讚! | 慕珊mio |
作者: 是你的泰初呀 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-08-09 14:48:18 評論於 Did you win?(0) 讚! | 是你的泰初呀 |
首頁 上一頁 1 2 3 下一頁 末頁 (頁 |
Contact us